# Bortezomib-Induced Superficial Vasculitis in a Kidney Transplant Recipient: A Rare Case

## TL;DR

A kidney transplant patient developed a rare skin reaction after receiving bortezomib, which resolved after reducing the drug dose.

## Contribution

This case report highlights a rare adverse effect of bortezomib in kidney transplant recipients.

## Key findings

- A 30-year-old kidney transplant recipient developed superficial vasculitis after bortezomib administration.
- The inflammation resolved spontaneously after three weeks and a dose reduction.
- Nephrologists should be aware of potential cutaneous adverse effects of bortezomib.

## Abstract

Bortezomib is a frequently administered immunosuppressive agent in kidney transplantation. A 30-year-old male kidney transplant recipient developed an atypical reaction on the left hand in terms of spider-like extensions, indicating erythematous inflammation along the superficial veins after bortezomib intravenous administration. The inflammation spontaneously resolved after three weeks with a bortezomib dose reduction. Nephrologists must be familiar with the potential cutaneous bortezomib-induced adverse effects.